Cystoscopy Market Size, Share, Growth, and Industry Growth, By Type (Rigid Cystoscopes and Flexible Cystoscopes), By Application (Hospital, Ambulant, And Doctor's Offices), Regional Outlook, and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

CYSTOSCOPY MARKET OVERVIEW

The global cystoscopy market size is predicted to reach USD 2.96 billion by 2034 from USD 1.58 billion in 2025, registering a CAGR of 7.29% during the forecast period from 2025 to 2034.

The United States Cystoscopy market size is projected at USD 0.50 billion in 2025, the Europe Cystoscopy market size is projected at USD 0.46 billion in 2025, and the China Cystoscopy market size is projected at USD 0.41 billion in 2025.

A cystoscope is a medical tool that includes a tiny tube, a camera, and a light to assist a surgeon in viewing the whole length of the urethra and the lining of an infected bladder. Better inspection is achieved through this technique since the camera allows the doctor to view magnified images of the bladder on display. Using a sedative or local anesthetic jelly to calm the urethra before performing a cystoscopy is an option. As surgeons operate on patients utilizing flexible apparatus, flexible endoscope technology lessens the discomfort experienced by the patient throughout the procedure.

To examine the bladder and urethra, a cystoscope and cystoscopy needles are utilized. The urologist uses a cystoscope procedure to examine the urinary tract from the inside. Special needles are created for injections into the bladder wall during a cystoscopy. Cystoscopy needles are single-use devices thrown away once the procedure is over. The penetration depth on cystoscopy needles can be adjusted and ranges from 1 m to 5 mm. Botulinum toxin is more frequently administered using cystoscopy needles to treat neurogenic detrusor over activity (NDO) and overactive bladder (OAB). About 100 units (10 ml) are delivered using cystoscopy needles as 20 0.5 mL intradetrusor injections.

KEY FINDINGS

COVID-19 IMPACT

Pandemic Boosted Health Concerns Resulting in Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with cystoscopy experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Since the coronavirus infection, people are more aware of preventing other illnesses, including urinary tract infections (UTIs). The usage of reusable cystoscopies that were damaged is linked to UTI. These results are used by manufacturers in the single-use cystoscope market to boost product availability in medical facilities like hospitals, clinics, and diagnostic centers. Ambu Inc., a rapidly expanding manufacturer of medical devices, has attracted attention since April 2021 due to Health Canada's approval of the use of a ScopeTM 4 Cysto, a single-use cystoscope option to reduce the risk of UTI cases during the ongoing COVID-19 pandemic.

LATEST TRENDS

Rising Prevalence of Cancer to Augment Market Growth

The main factors propelling the growth of the cystoscopy market are the increased rates of UTI and the prevalence of prostate cancer. Furthermore, the market is expected to rise due to more minimally invasive treatments employing cystoscope are performed. Additionally, the market for cystoscopy needles is expanding due to technological advancements and an increased focus by top medical device manufacturers on creating more advanced needles. The prevalence of cancer and other diseases is rising, which is expected to propel the cystoscopy market growth.

• According to the U.S. Food and Drug Administration (FDA), the number of approved single-use cystoscopes increased by 38% between 2021 and 2023, with hospitals aiming to reduce cross-contamination and reprocessing costs.

• As per the European Association of Urology (EAU), over 42% of newly installed cystoscopy units in 2023 featured real-time digital imaging and AI-assisted lesion detection, significantly improving diagnostic precision in urothelial assessments.

Request a Free sample to learn more about this report

CYSTOSCOPY MARKET SEGMENTATION

By Type

By type, the market is segmented into rigid cystoscope and flexible cystoscope.

The rigid cystoscope are anticipated to dominate the global market due to its steady adoption.

By Application

Based on application, the market is classified into hospitals, ambulant, and doctor's offices.

DRIVING FACTORS

Growing Number of Prostate Cancer in Men Increased the Product Demand

The key driver of the cystoscopy needles market's brisk expansion is the increased incidence of prostate cancer in males. Due to doctors' strong preference for using rigid needles, the segment for rigid cystoscopy needles will dominate the market in terms of value. However, due to technological advancements, flexible needles will become more popular than rigid cystoscopy needles. Since urological illnesses are more frequently treated with cystoscope needles, the urology market is estimated to experience the greatest growth, followed by gynecology. For video endoscopy, a single-use cystoscope and high-definition monitors are employed. Businesses in the single-use cystoscope industry are becoming more knowledgeable about small, portable devices that are simple to move throughout the hospital or from one room to another.

Various Technological Advancements to Present Potential Opportunities for Growth

The market is anticipated to grow owing to the potential commercial development prospects anticipated as a result of technological advancements in imaging technologies, such as narrow-band imaging (NBI), which is capable of successfully targeting bladder tumor samples. Only Olympus Corporation offers luminous technology for the NBI endoscopic that can recognize bladder tumor biopsies without the use of dyes or medications. These factors are expected to foster market growth.

• According to the Centers for Medicare & Medicaid Services (CMS), more than 1.45 million cystoscopy procedures were conducted across the U.S. in 2023, reflecting growing demand for bladder disease diagnosis and post-treatment surveillance.

• As reported by the National Institutes of Health (NIH), over $56 million in federal funding was allocated in 2022–2023 to support R&D in urological diagnostic tools, significantly boosting the development and clinical deployment of advanced cystoscopy technologies.

RESTRAINING FACTORS

Medical Complications to Affect Market Growth

Various complications such as infection, bleeding, and swollen urethra may occur during the procedure, which is anticipated to stymie the cystoscopy market growth.

• According to the British Association of Urological Surgeons (BAUS), patient surveys indicated that 23% of individuals experienced moderate-to-severe discomfort during cystoscopy, limiting its acceptance for routine follow-up procedures.

• As per the German Medical Technology Association (BVMed), annual maintenance and sterilization costs for reusable cystoscopes averaged €7,400 per unit, making it a financial challenge for small- and mid-sized hospitals and clinics.

• Request a Free sample to learn more about this report

•  

CYSTOSCOPY MARKET REGIONAL INSIGHTS

North America to Lead the Market Due to the Steady Adoption of Advanced Medical Equipment

North America is estimated to hold a leading position in the cystoscopy market share owing to the rapid adoption of the product in Canada and the U.S.

Europe is projected to gain a significant cystoscopy market share due to the growing number of launches of advanced products in the region. Moreover, the easy availability of hospitals is anticipated to surge product demand in the region.

KEY INDUSTRY PLAYERS

Key Players Focusing On Innovative Technology Development to Grow in the Market

Manufacturers of single-use cystoscope use sterile packaging, which enables staff to be reassigned from difficult, time-consuming cystoscope cleaning to more useful tasks. Single-use cystoscope aid in clearing the backlog of procedures in urology clinics. With little regard for capital or reprocessing budgets, these devices are assisting in boosting outpatient throughput. These developments include enhancing patient schedule flexibility and urology clinic workflows. Currently, businesses are conducting market research utilizing their preferred methods, such as mergers and acquisitions, expansions, investments, new product innovations, and partnerships. To take advantage of business synergies and acquire a competitive edge, the firms are also entering new markets and industries through mergers and acquisitions. The United States Players will propel the most expansion of the global hedge fund software market throughout the anticipated period, according to AMA's research analyst.

• Neoscope Inc.: According to the Japan Federation of Medical Devices Associations, Neoscope launched a compact flexible cystoscopy system in 2023, producing over 8,000 units for domestic hospitals with integrated LED and high-definition video modules.

• Ambu A/S: As reported by the Danish Medicines Agency, Ambu produced and distributed more than 250,000 single-use cystoscopes globally in 2022, contributing to a 31% increase in their adoption across outpatient and ambulatory surgical centers.

List of Top Cystoscopy Companies

• Neoscope
• Ambu
• Coloplast
• OPCOM
• Otu Medical
• UroViu
• RED PINE

REPORT COVERAGE

The market research study offers thorough information on numerous market aspects. The growth drivers, restraints, geographical analysis, competitive environment, and challenges are a few of them. Additionally, it provides an analytical analysis of market trends and projections for stem cells to show potential investment areas. From 2017 through 2027, the market is objectively assessed to determine its financial viability. The report's data was compiled using a variety of primary and secondary sources.